statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Clearmind Medicine Inc. (NASDAQ:CMND  Get Free Report) saw a significant decline in short interest in March. As of March 15th, there was short interest totalling 92,700 shares, a decline of...

Short Interest in Clearmind Medicine Inc. (NASDAQ:CMND) Declines By 59.8%

TEL AVIV, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...

SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression

Vancouver, Canada, March 27, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY) ( Clearmind or the company ), a biotech company focused on discovery and development of...

Clearmind Medicine Announces International Patent Application for Preventing and Treating Depression

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Clearmind Medicine granted divisional patent approval in China

A Novel Approach to Combatting Binge Behaviors with Groundbreaking Psychedelic Therapy Tel Aviv, Israel / Vancouver, Canada, March 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq...

Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China

Clearmind Medicine (NASDAQ:CMND  Get Free Report) and ABVC BioPharma (NASDAQ:ABVC  Get Free Report) are both small-cap medical companies, but which is the better investment? We will...

Clearmind Medicine (NASDAQ:CMND) and ABVC BioPharma (NASDAQ:ABVC) Head-To-Head Analysis

TEL AVIV, Israel, Feb. 27, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...

SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds

Clearmind Medicine submits three international patent applications

TEL AVIV, Israel, Feb. 20, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...

SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds

Clearmind Medicine receives Patent Approval in China for treatment of binge behaviours...

Clearmind Medicine receives Patent Approval in China for treatment of binge behaviours

Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.

Watchers	2,450
52-Wk Low	$0.9205
52-Wk High	$23.70

Volume	49.47M
52-Wk High	$23.70
52-Wk Low	$0.9205

CMND Clearmind Medicine Inc

About

Feed

News

Fundamentals